[01:37:41] [INFO] 
================================================================================
[01:37:41] [INFO]   DATA ARCHAEOLOGY PIPELINE
[01:37:41] [INFO] ================================================================================

[01:37:41] [INFO] Starting forensic inspection of datasets...
[01:37:41] [INFO] 
================================================================================
[01:37:41] [INFO]   PHASE 1: CLINICAL DATA ARCHAEOLOGY
[01:37:41] [INFO] ================================================================================

[01:37:41] [INFO] Reading clinical.tsv (raw)...
[01:37:41] [INFO] First 5 lines of clinical.tsv:
[01:37:41] [INFO]   Line 0: project.project_id	cases.case_id	cases.consent_type	cases.days_to_consent	cases.days_to_lost_to_foll...
[01:37:41] [INFO]   Line 1: TCGA-BRCA	001cef41-ff86-4d3f-a140-a647ac4b10a1	Informed Consent	-34	'--	Ductal and Lobular Neoplasms...
[01:37:41] [INFO]   Line 2: TCGA-BRCA	001cef41-ff86-4d3f-a140-a647ac4b10a1	Informed Consent	-34	'--	Ductal and Lobular Neoplasms...
[01:37:41] [INFO]   Line 3: TCGA-BRCA	001cef41-ff86-4d3f-a140-a647ac4b10a1	Informed Consent	-34	'--	Ductal and Lobular Neoplasms...
[01:37:41] [INFO]   Line 4: TCGA-BRCA	0045349c-69d9-4306-a403-c9c1fa836644	Informed Consent	76	'--	Adenomas and Adenocarcinomas	...
[01:37:41] [INFO] ‚úì Read with skiprows=[1]: shape=(5545, 210)
[01:37:41] [INFO] ‚úì Read without skip: shape=(5546, 210)
[01:37:41] [WARN] ‚ö†Ô∏è  WARNING: Different shapes with/without skiprows!
[01:37:41] [INFO]    Difference: 1 rows
[01:37:41] [INFO] 
üìä CLINICAL DATA OVERVIEW:
[01:37:41] [INFO]   Shape: 5545 rows √ó 210 columns
[01:37:41] [INFO]   Memory usage: 62.88 MB
[01:37:41] [INFO] 
üìã COLUMN INVENTORY:
[01:37:41] [INFO]   Total columns: 210
[01:37:41] [INFO] 
  Column prefixes:
[01:37:41] [INFO]     diagnoses: 132 columns
[01:37:41] [INFO]     treatments: 46 columns
[01:37:41] [INFO]     demographic: 22 columns
[01:37:41] [INFO]     cases: 9 columns
[01:37:41] [INFO]     project: 1 columns
[01:37:41] [INFO] 
üîë KEY COLUMNS CHECK:
[01:37:41] [INFO]   ‚úì cases.case_id: 5545/5545 (100.0%) non-null
[01:37:41] [INFO]   ‚úì cases.submitter_id: 5545/5545 (100.0%) non-null
[01:37:41] [INFO]   ‚úì demographic.vital_status: 5545/5545 (100.0%) non-null
[01:37:41] [INFO]   ‚úì diagnoses.age_at_diagnosis: 5545/5545 (100.0%) non-null
[01:37:41] [INFO]   ‚úì diagnoses.ajcc_pathologic_stage: 5545/5545 (100.0%) non-null
[01:37:41] [INFO]   ‚úì diagnoses.primary_diagnosis: 5545/5545 (100.0%) non-null
[01:37:41] [INFO] 
üîç DUPLICATE ANALYSIS:
[01:37:41] [INFO]   Before dedup: 5545 rows
[01:37:41] [INFO]   After dedup:  1098 rows
[01:37:41] [INFO]   Removed: 4447 duplicates
[01:37:41] [INFO] 
üíÄ VITAL STATUS DISTRIBUTION:
[01:37:41] [INFO]   Alive: 945 (86.1%)
[01:37:41] [INFO]   Dead: 152 (13.8%)
[01:37:41] [INFO]   '--: 1 (0.1%)
[01:37:41] [INFO] 
üìÖ AGE AT DIAGNOSIS:
[01:37:41] [INFO]   Non-null: 1050 / 1098
[01:37:41] [INFO]   Min: 9840
[01:37:41] [INFO]   Median: 21558
[01:37:41] [INFO]   Max: 32872
[01:37:41] [WARN]   ‚ö†Ô∏è  Age appears to be in DAYS (median=21558)
[01:37:41] [INFO]   Converting to years: 59.0 years
[01:37:41] [INFO] 
üéöÔ∏è  STAGE DISTRIBUTION:
[01:37:41] [INFO]   Stage IIA: 334
[01:37:41] [INFO]   Stage IIB: 235
[01:37:41] [INFO]   Stage IIIA: 138
[01:37:41] [INFO]   '--: 102
[01:37:41] [INFO]   Stage IA: 85
[01:37:41] [INFO]   Stage I: 83
[01:37:41] [INFO]   Stage IIIC: 56
[01:37:41] [INFO]   Stage IIIB: 23
[01:37:41] [INFO]   Stage IV: 18
[01:37:41] [INFO]   Stage II: 7
[01:37:41] [INFO] 
üè• DIAGNOSIS TYPES:
[01:37:41] [INFO]   Infiltrating duct carcinoma, NOS: 752
[01:37:41] [INFO]   Lobular carcinoma, NOS: 186
[01:37:41] [INFO]   Not Reported: 35
[01:37:41] [INFO]   Infiltrating duct and lobular carcinoma: 28
[01:37:41] [INFO]   Infiltrating duct mixed with other types of carcinoma: 18
[01:37:41] [INFO]   Mucinous adenocarcinoma: 15
[01:37:41] [INFO]   Metaplastic carcinoma, NOS: 13
[01:37:41] [INFO]   Infiltrating lobular mixed with other types of carcinoma: 6
[01:37:41] [INFO]   Intraductal papillary adenocarcinoma with invasion: 6
[01:37:41] [INFO]   Medullary carcinoma, NOS: 5
[01:37:41] [INFO] 
‚úì Saved deduplicated clinical data to reports/
[01:37:41] [INFO] 
================================================================================
[01:37:41] [INFO]   PHASE 2: MUTATION MATRIX ARCHAEOLOGY
[01:37:41] [INFO] ================================================================================

[01:37:41] [INFO] Reading mutation matrix...
[01:37:42] [INFO] 
üìä MUTATION MATRIX OVERVIEW:
[01:37:42] [INFO]   Shape: 967 patients √ó 15414 genes
[01:37:43] [INFO]   Memory usage: 119.29 MB
[01:37:43] [INFO]   Patients: 967
[01:37:43] [INFO]   Genes: 15413
[01:37:43] [INFO] 
üß¨ MUTATION FREQUENCY STATS:
[01:37:43] [INFO]   Total mutations: 63603
[01:37:43] [INFO]   Mean mutations per gene: 4.13
[01:37:43] [INFO]   Median mutations per gene: 3
[01:37:43] [INFO]   Max mutations (single gene): 331
[01:37:43] [INFO] 
üï≥Ô∏è  SPARSITY ANALYSIS:
[01:37:43] [INFO]   Total cells: 14,904,371
[01:37:43] [INFO]   Mutated cells: 63,603
[01:37:43] [INFO]   Sparsity: 99.57%
[01:37:43] [INFO] 
üîù TOP 20 MUTATED GENES:
[01:37:43] [INFO]    1. TP53: 331 (34.2%)
[01:37:43] [INFO]    2. PIK3CA: 328 (33.9%)
[01:37:43] [INFO]    3. TTN: 167 (17.3%)
[01:37:43] [INFO]    4. CDH1: 128 (13.2%)
[01:37:43] [INFO]    5. GATA3: 125 (12.9%)
[01:37:43] [INFO]    6. MUC16: 99 (10.2%)
[01:37:43] [INFO]    7. KMT2C: 85 (8.8%)
[01:37:43] [INFO]    8. MAP3K1: 82 (8.5%)
[01:37:43] [INFO]    9. HMCN1: 58 (6.0%)
[01:37:43] [INFO]   10. FLG: 56 (5.8%)
[01:37:43] [INFO]   11. RYR2: 55 (5.7%)
[01:37:43] [INFO]   12. SYNE1: 53 (5.5%)
[01:37:43] [INFO]   13. PTEN: 52 (5.4%)
[01:37:43] [INFO]   14. USH2A: 51 (5.3%)
[01:37:43] [INFO]   15. NCOR1: 49 (5.1%)
[01:37:43] [INFO]   16. ZFHX4: 47 (4.9%)
[01:37:43] [INFO]   17. SPTA1: 46 (4.8%)
[01:37:43] [INFO]   18. DMD: 44 (4.6%)
[01:37:43] [INFO]   19. MUC17: 43 (4.4%)
[01:37:43] [INFO]   20. NEB: 42 (4.3%)
[01:37:43] [INFO] 
ü¶Ñ RARE MUTATION DISTRIBUTION:
[01:37:43] [INFO]   Genes with ‚â§ 1 mutations:  3577 (23.2%)
[01:37:43] [INFO]   Genes with ‚â§ 2 mutations:  6758 (43.8%)
[01:37:43] [INFO]   Genes with ‚â§ 5 mutations: 12010 (77.9%)
[01:37:43] [INFO]   Genes with ‚â§10 mutations: 14570 (94.5%)
[01:37:43] [INFO]   Genes with ‚â§20 mutations: 15268 (99.1%)
[01:37:43] [INFO]   Genes with ‚â§50 mutations: 15399 (99.9%)
[01:37:43] [INFO] 
üë§ PATIENT MUTATION BURDEN:
[01:37:43] [INFO]   Min: 1
[01:37:43] [INFO]   25th percentile: 22
[01:37:43] [INFO]   Median: 33
[01:37:43] [INFO]   75th percentile: 59
[01:37:43] [INFO]   Max: 3621
[01:37:43] [INFO] 
üö® DATA QUALITY CHECKS:
[01:37:43] [INFO]   ‚úì No all-zero genes
[01:37:43] [INFO]   ‚úì No all-one genes
[01:37:43] [INFO]   ‚úì All checked genes are binary (0/1)
[01:37:43] [INFO]   ‚úì No missing patient IDs
[01:37:43] [INFO] 
================================================================================
[01:37:43] [INFO]   PHASE 3: CROSS-DATASET VALIDATION
[01:37:43] [INFO] ================================================================================

[01:37:43] [INFO] üìá PATIENT ID OVERLAP:
[01:37:43] [INFO]   Clinical IDs: 1098
[01:37:43] [INFO]   Mutation IDs: 967
[01:37:43] [INFO] 
  Overlap: 967 patients
[01:37:43] [INFO]   Clinical only: 131 patients
[01:37:43] [INFO]   Mutation only: 0 patients
[01:37:43] [WARN] 
  ‚ö†Ô∏è  131 patients in clinical but not in mutations
[01:37:43] [INFO]      Sample IDs: ['TCGA-AO-A1KO', 'TCGA-A2-A3XX', 'TCGA-AC-A3EH', 'TCGA-JL-A3YX', 'TCGA-E9-A5UP']
[01:37:43] [INFO] 
üí• EXPECTED DATA LOSS (inner join):
[01:37:43] [INFO]   Merged dataset will have: 967 patients
[01:37:43] [INFO]   Lost from clinical: 131 (11.9%)
[01:37:43] [INFO]   Lost from mutation: 0 (0.0%)
[01:37:43] [INFO] 
================================================================================
[01:37:43] [INFO]   PHASE 4: VISUALIZATION GENERATION
[01:37:43] [INFO] ================================================================================

[01:37:43] [INFO] Generating diagnostic plots...
[01:37:44] [INFO]   ‚úì Saved clinical_structure.png
[01:37:44] [INFO]   ‚úì Saved mutation_sparsity.png
[01:37:44] [INFO] 
================================================================================
[01:37:44] [INFO]   PHASE 5: QUALITY REPORT GENERATION
[01:37:44] [INFO] ================================================================================

[01:37:44] [INFO] ‚úì Saved quality flags: reports/data_quality_flags.json